PubMed=8217948
Hidenori Sasa, Atsushi Hisano, Kenji Ishii, Junko Hirata, Yoshihiro Kikuchi, Ichiro Nagata, Akira Senoo, Shinsuke Aida, Seiichi Tamai, Michio Sugita;
Establishment of a cisplatin-resistant human ovarian cancer cell line.
Hum. Cell 6:106-113(1993)

PubMed=8375936; DOI=10.1002/ijc.2910550332
Junko Hirata, Yoshihiro Kikuchi, Tsunekazu Kita, Eiji Imaizumi, Takehiko Tode, Kenji Ishii, Kazuya Kudoh, Ichiro Nagata;
Modulation of sensitivity of human ovarian cancer cells to cis-diamminedichloroplatinum(II) by 12-O-tetradecanoylphorbol-13-acetate and D,L-buthionine-S,R-sulphoximine.
Int. J. Cancer 55:521-527(1993)

PubMed=7844449
Kenji Ishii, Tsunekazu Kita, Kazuya Kudo, Atsushi Hisano, Junko Hirata, Eiji Imaizumi, Takehiko Tode, Yoshihiro Kikuchi, Ichiro Nagata;
Circumvention of cisplatin resistant ovarian cancer cells by antiestrogens.
Nihon Sanka Fujinka Gakkai Zasshi 47:19-26(1995)

PubMed=17671176; DOI=10.1158/0008-5472.CAN-06-4567
Ryoko Kikuchi, Hitoshi Tsuda, Yae Kanai, Takahiro Kasamatsu, Kazuo Sengoku, Setsuo Hirohashi, Johji Inazawa, Issei Imoto;
Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Cancer Res. 67:7095-7105(2007)